Status
Conditions
Treatments
About
interfragmentary gap measurement using Herbert cannulated headless screw using a 3D surgical customized template versus titanuim plate
Full description
Intervention for each group
Diagnosis
Surgical planning Group I :participants will be treated using Herbert headless cannulated screw(Zimmer® Herbert™ ,united states of America )Cannulated Bone Screw) using 3d template GroupII :patients are treated using titanium plates (4 or 6 holes according to each case) orthomed ,6th of October,Egypt)
Intra-operative procedures:
-All of the participants will be treated under general anaesthesia using nasal intubation
Reduction of the fracture -Fixation of the fractured segments through Herbert screw using the 3D template fabricated by Plastycad 3diemme Italy(group I), or by using titanium the plate (groupII)
-Double checking and verification of the occlusion before wound closure.
-Wounds are debrided and sutured.
Postoperative
-Broad spectrum antibiotic therapy in the form of Unasyn 1500 mg vials was given as an IV shot to the patient every 12 hours for 5 days to reduce the risk of infection. (Unasyn®: manufactured by Pfizer, Egypt S.A.E Cairo, A.R.E)
Follow up & Evaluation
Clinical follow up parameters:
For group I and group II - Dehiscence of the soft tissue and hardware exposure. - Pain over visual analogue scale over first 72 hours.
Radiographic follow up parameters:
The the MIO will be tested for all patients under the same chair postion using the same caliper, the visual analogue scale to measure the pain will be explained to the patient to prevent any misunderstanding and for the sensory function the patients will be asked to close their eyes before we start to prevent any misleading data as he will not be able to see area we are checking. Those Strategies will be used to improve adherence to intervention protocols.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
patient age between 20 to 45
Exclusion criteria
.Patients receiving chemotherapy or radiotherapy "due to the risk of low bone quality and healing.(Hopewell, 2003)
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Loading...
Central trial contact
Nevine AE Fathy mohammed elfath omar, a lecturer; omnia i sultan, lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal